Table 1.
Baseline | 96 Weeks | ||||
---|---|---|---|---|---|
Lipid type and cutoff for dyslipidemia |
Mean (95% CI) |
Dyslipidemic N(%) |
Mean (95% CI) |
Dyslipidemic N(%) |
P Value |
Triglycerides, mg/dL Dyslipidemic: ≥130 mg/dL |
152.5 (137.5, 167.6) |
87(50.3%) | 165.0 (149.0, 180.9) |
80(53.3%) | 0.006 |
HDL, mg/dL Dyslipidemic: <40 mg/dL |
37.9 (36.6, 39.2) |
107(61.8%) | 35.1 (33.9, 36.3) |
110(73.3%) | <0.001 |
Total cholesterol,mg/dL Dyslipidemic: ≥200 mg/dL |
176.3 (170.3,182.4) |
41(23.7%) | 169.8 (163.6,175.9) |
25(16.7%) | 0.02 |
LDL, mg/dL Dyslipidemic: ≥130 mg/dL |
108.8 (104.3,113.4) |
37(21.5%) | 103.4 (98.2,108.7) |
26(17.9%) | 0.004 |
Non-HDL-C, mg/dL Dyslipidemic: ≥145 mg/dL |
138.5 (132.6,144.3) |
61(35.2%) | 134.6 (128.6,140.7) |
54(36.0%) | 0.15 |
Triglycerides/HDL Combined dyslipidemia of obesity: >3.0 |
4.3 (3.8, 4.8) |
99(57.2%) | 5.0 (4.4, 5.5) |
103(59.5%) | <0.001 |
Adapted from the National Heart, Lung and Blood Institute(NHLBI) Expert Panel Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents.1